You are viewing the site in preview mode

Skip to main content

Table 2 Absolute contributions of diseases to educational disparity in disability prevalence in baseline situation and under counterfactual scenarios, the Disability Health Survey, France, 2008–2009. Results are % (95% CI)

From: Contribution of chronic diseases to educational disparity in disability in France: results from the cross-sectional “disability-health” survey

  Contributions of Diseases to Total Prevalence of Disability
Among Groups with a Tertiary and Elementary Education, Percentage Points
Difference Between Elementary and Tertiary Education
Representing Contribution to Disability Disparity, Percentage Points
Primary (1) Tertiary (2) Primary, counterfactual with disease prevalence of tertiary (3) Primary, counterfactual with disabling Impact of Tertiary (4) Baseline Situation (No Counterfactual) (1–2) Counterfactual With Disease Prevalence of primary Equal to Tertiary (3–2) a Counterfactual with disabling Impact of primary equal to tertiary (4–2) b
Men
 Spine disorders 3.8 (3.6–4.0) 1.9 (1.8–2.1) 3.2 2.3 1.9 1.3 0.4
 Arthritis 5.7 (5.4–6.0) 3.3 (3.0–3.9) 3.4 5.3 2.4 0.1 2.0
 Dementia 0.6 (0.6–0.6) 1.2 (0.9–1.6) 0.5 1.2 −0.6 − 0.7 0.0
 Stroke 1.0 (0.9–1.0) 0.5 (0.5–0.6) 0.7 0.6 0.5 0.2 0.1
 Neurologic diseases 1.0 (0.9–1.0) 0.4 (0.4–0.4) 0.7 0.6 0.6 0.3 0.2
 Ischemic heart diseases/PAD 4.1 (3.9–4.3) 2.4 (2.2–3.0) 2.8 3.7 1.7 0.4 1.3
 Other heart diseases 1.8 (1.7–1.9) 1.3 (1.1–1.7) 2.0 1.2 0.5 0.7 −0.1
 COPD 2.4 (2.3–2.6) 0.6 (0.5–0.7) 1.5 1.0 1.8 0.9 0.4
 Psychiatric diseases 2.6 (2.5–2.8) 1.2 (1.1–1.3) 1.6 1.8 1.4 0.4 0.6
 Sensorial diseases 0.3 (0.3–0.3) 0.0 (0.0–0.0) 0.1 0.1 0.3 0.1 0.1
 Cancer 1.2 (1.1–1.2) 0.6 (0.6–0.8) 0.7 1.0 0.6 0.1 0.4
 Diabetes 1.4 (1.4–1.5) 0.7 (0.7–0.8) 0.9 1.2 0.7 0.2 0.5
 Accidents 2.4 (2.3–2.5) 1.0 (0.9–1.1) 1.2 1.5 1.4 0.2 0.5
 Background 10.7 (10.2–11.3) 5.7 (5.3–6.4) 11.6 11.4 5.0 5.9 5.7
 Disability prevalence 38.9 (37.3–41.0) 20.9 (19.2–24.0) 30.8 32.8 18 9.9 11.9
Women
 Spine disorders 4.5 (4.3–4.7) 2.1 (1.9–2.3) 4.5 2.0 2.4 2.4 −0.1
 Arthritis 9.5 (9.1–9.9) 4.5 (4.1–5.2) 7.0 6.6 5.0 2.5 2.1
 Dementia 0.7 (0.7–0.8) 0.4 (0.3–0.5) 0.5 1.0 0.3 0.1 0.6
 Stroke 0.7 (0.6–0.7) 0.8 (0.7–1.1) 0.8 1.2 −0.1 0.0 0.4
 Neurologic diseases 1.1 (1.0–1.2) 0.7 (0.7–0.8) 0.8 0.9 0.4 0.1 0.2
 Ischemic heart diseases/PAD 1.5 (1.4–1.6) 0.7 (0.6–0.8) 1.5 0.7 0.8 0.8 0.0
 Other heart diseases 2.2 (2.1–2.3) 1.8 (1.6–2.3) 2.9 1.7 0.4 1.1 −0.1
 COPD 1.1 (1.0–1.1) 1.8 (1.6–2.1) 1.0 1.8 −0.7 −0.8 0.0
 Psychiatric diseases 3.1 (3.0–3.3) 1.1 (1.0–1.3) 1.9 1.9 2.0 0.8 0.8
 Sensorial diseases 0.3 (0.3–0.3) 0.2 (0.2–0.2) 0.2 0.2 0.1 0.0 0.0
 Cancer 1.4 (1.3–1.5) 2.2 (2.0–2.6) 1.5 1.9 −0.8 −0.7 −0.3
 Diabetes 1.8 (1.8–1.9) 0.6 (0.5–0.7) 0.4 2.2 1.2 −0.2 1.6
 Accidents 0.5 (0.5–0.6) 1.7 (1.5–1.9) 0.8 1.5 −1.2 −0.9 − 0.2
 Background 14.0 (13.5–14.6) 11.1 (9.7–13.9) 14.3 14.7 2.9 3.2 3.6
 Disability prevalence 42.3 (40.9–44.1) 29.7 (26.7–35.2) 38.0 37.8 12.6 8.3 8.1
  1. aThis represents the part of educational disparity explained by the difference of disabling impact of diseases between the primary and the tertiary educational level group
  2. bThis represents the part of educational disparity explained by the difference of diseases prevalence between the primary and the tertiary educational level group
  3. PAD Peripheral Artery Diseases, COPD Chronic Obstructive Pulmonary Diseases
  4. Contributions were age-standardized to the French population of men and women estimated by the 2009 census (French National Institute of Statistics and Economic Studies). There were 23,348 respondents 25 years and older